Impacto da terapia periodontal na mucosite oral e identificação de microrganismos orais prevalentes
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Background: Periodontal disease (PD) and oral mucositis (OM) are
immunoinflammatory conditions that can be characterized by the constant presence
of systemic inflammation and bacteremia. Objective: Evaluate the impact of
periodontal therapy in oral mucositis and investigate the occurrence of putative
periodontal pathogens in patients undergoing chemotherapy for solid tumors and
scheduled for hematopoietic stem cell transplantation (HSCT). Methods: This study
included an evaluation of demographic data, data chemotherapy and comorbidities,
and global systematic dental assessment. These were obtained prior and between 7-
14 days after initiated chemotherapy in periodontal health group (PH group). The
Periodontal disease Group (PD Group) was evaluated during 7 to 14 days after of
chemotherapy. The oral mucosa also was examined for scoring of chemotherapyinduced
oral mucositis. Furthermore clinical tests for dysphagia diagnosis and
evaluation of xerostomia and quality of life related to oral health; socio-economic
class of patients was determined. Subgengival samples were collected by inserting
sterile paper points for both groups, for same periods described above. Total number
of bacterial cells and cells from each species determined by FISH (fluorescence in
situ hybridization). Results: Fifty-one patients with solid tumors and scheduled for
HSCT were assessed to evaluate the impact of periodontitis in OM. Mean age was
51.12, 38(74.5%) were female and socio-economic Class C 22(43.1%) was
prevalent. The primary tumor site was most commonly breast cancer 21(41.1%) and
prevalent chemotherapeutic agent was doxorubicin 22(43.1%). The prevalent
morbidity associated was hypertension 20(39.2%). PH Group included 33 patients
and PD Group enrolled 18 patients. Statistical analyses revealed that the
distributions of patients with incidence of OM did not differ between both groups. The
majority incidence of grade 1 chemotherapy-induced OM was observed.
Sixteen(31%) patients developed oral mucositis, 9(56.2%) in patients undergoing
conditioning regimen prior HSCT, and 7(43.7%) in patients undergoing common
chemotherapy for solid tumors. Patients with oral complications showed a mean
OHIP-14 index of 1.36, while those who did not develop oral complications had a
mean OHIP-14 of 0.56, after chemotherapy for solid tumors. Conclusion: This study
demonstrated that oral health, could affect experience and incidence of chemoinduced
OM. When only patients periodontally healthy undergoing conditioning
regimen of therapy and conventional chemotherapy were observed, was noted a
lower incidence of oral mucositis, when compared with scientific evidences. The
need of inclusion of patients with severe periodontitis to evaluate this relationship
hampers such trial.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
Acesso Aberto
